PATHWAY PROFILING ANTIBODIES & REAGENTS

     
Products
Product : Clinical Tissue >> Human Cervix Tissue Lysate Bundle Set
Back  >   Printable Version  >  Download in PDF  > 
Human Cervix Tissue Lysate Bundle Set, Cat. No. C004-023

Cat No Description Units Price
C004-023 Human Cervix Tissue Lysate Bundle Set 4 Vials --

Tissue Bundled Set contains the following tumor & normal adjacent lysates (below). Lysates may also be purchased individually.

Extraction 1, Soluble Protein Fraction
C004-023T1 Human Cervix Tumor Tissue Lysate 0.1 mg --
C004-023N1 Human Cervix Normal Tissue Lysate (matched) 0.1 mg --

Extraction 2, Insoluble Protein Fraction
C004-023T2 Human Cervix Tumor Tissue Lysate 0.1 mg --
C004-023N2 Human Cervix Normal Tissue Lysate (matched) 0.1 mg --

Diagnosis: Squamous cell cervical carcinoma, moderately differentiated Grade: 2
Stage: IIIb Sex: Female
TNM: T1N1M0 Quantity: 100
Age: 49
Concentration: 1 mg/ml
The vial is provided with a 10% overfill. Maximum recovery can be obtained by centrifuging the vial briefly to collect any solution on the cap and tube sides.
Storage: Aliquot single use volumes to avoid repeated freeze/thaw cycles. From time of receipt, this product is stable for 12 months at –70°C.
Lysate Preparation : Tissue specimens are homogenized in modified RIPA buffer to obtain the soluble proteins, and centrifuged to clarify. The pellet was further extracted with a second buffer to obtain the less soluble protein fraction. The lysate solution may appear turbid at cold temperatures due to insolubility of buffer components. The solution should clear upon warming to room temperature.
Extraction 1: PBS, pH 7.4 1 µg/ml Aprotinin 1 mM NaF
Modified RIPA Buffer: 1 mM EDTA 1 µg/ml Pepstatin-A 0.1% SDS
0.25% Na deoxycholate 1 µg/ml Leupeptin 1 mM PMSF
1 mM Na3VO4
Extraction 2: PBS, pH 7.4, 5.0 M Urea, 2.0 M Thiourea, 50mM DTT, 0.1% SDS
Usage: These lysates are proteomic discovery tools. Researchers should validate and optimize for individual use. Potential applications MAY include WB, immunoprecipitation, protein-protein interactions, ligand binding, ELISA.
Note: For use in 1D and 2D gel electrophoresis, the addition of a denaturing gel loading buffer with reducing agents may be required.
Warranty: The products sold hereunder are warranted only to conform to the quantity and contents stated on the label at the time of delivery to the customer. There are no warranties, expressed or implied, that extend beyond the description on the label of the product. IMGENEX’s sole liability is limited to either replacement of the products or refund of the purchase price. IMGENEX is not liable for property damage, personal injury, or economic loss caused by the product.
Precautions: This material has tested negative for HbsAg, HIV 1/2, and HCV. Use UNIVERSAL PRECAUTIONS when handling. Human tissue derivatives must be treated as a potentially infectious agent and disposed of appropriately.

PATHOLOGY REPORT
Catalog Numbers: C004-023
Tissue: Normal
Location: Cervix
Diagnosis: Squamous cell cervical carcinoma, moderately differentiated
Stage: IIIb
Grade: 2
Sex: Female
Age: 49
Appearance:
Macroscopic:
Organ: Cervix Size: 3 x 3 cm. Color: Red-white. Consistency: Soft Cut surface Non identical
Characteristics:
Encapsulated: - Invaded: - Hemorrhagic: + Cystic degeneration: - Calcification: -
Histologic pattern:
Cell Distribution:
Diffuse: -
Mosaic: -
Necrosis: -
Lymphocytic infiltration: +
Vascular invasion: -
Clusterized: -
Alveolar formation: -
Indian file: -
Structure:
Streaming: -
Storiform: -
Fibrosis: -
Pallisading: -
Cystic degeneration: -
Bleeding: -
Myxoid change: -
Psammoma body: -
Cellular differentiation:
Squamous:
Squamoid: +
Spindle: -
Keratin: -
Desmosome: -
Pearl: -
Adenomatous:
Glandular cell: +
Cell stratification: -
Secretion: -
Intracellular vacuole: -
Glandular formation: +
Sarcomatous:
Round cell: -
Spindle cell: -
Leiomyoblast: -
Lipoblast: -
Rhadomyoblast: -
Nuclear atypia: Anisonucleosis: II
Hyperchomatism: II
Nucleolar prominent: II
Multinucleated giant cell: II
Mitotic activity: II
Nuclear grade: II

Products

Services

Resources

Purchasing

Company

  • What's New
  • Reporter Cells
  • Screening Services
  • Interactive Pathways